Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
37,158,995
-
Share change
-
+3,068,739
-
Total reported value
-
$297,320,064
-
Price per share
-
$8.00
-
Number of holders
-
73
-
Value change
-
-$67,213,341
-
Number of buys
-
41
-
Number of sells
-
40
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q3 2021
As of 30 Sep 2021,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,158,995 shares.
The largest 10 holders included
Bellevue Group AG, JANUS HENDERSON GROUP PLC, Blackstone Inc, Soleus Capital Management, L.P., BVF INC/IL, RTW INVESTMENTS, LP, Avidity Partners Management LP, EVENTIDE ASSET MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and Vivo Capital, LLC.
This page lists
73
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.